Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effect of Prewarming Duration on Blood Flow After Colon Resection Surgery

30 septembre 2026 mis à jour par: Çiğdem Ünal Kantekin

Evaluation of the Effect of Preoperative Prewarming Duration on Postoperative Perfusion Index in Patients Undergoing Colon Resection Surgery: A Randomized Controlled Trial

This study will examine whether warming patients before colon resection surgery improves blood flow in the fingers during early recovery from general anesthesia. It will also compare two warming durations. A total of 108 adults scheduled for elective colon resection surgery at Kayseri City Hospital will be assigned by chance to one of three groups: 10 minutes of warming before anesthesia, 30 minutes of warming before anesthesia, or no active warming before anesthesia. All three groups will receive warming during surgery as part of routine care.

Warming will be provided using a forced-air warming system. After surgery, a sensor placed on a finger will measure the perfusion index, a noninvasive indicator of blood flow, on arrival in the recovery unit and 5 and 10 minutes later. The main comparison will use the average of these three measurements. The researchers will also assess other circulation measurements, routine blood gas and lactate results, shivering, pain, the time until oral feeding begins, and wound infection during the 14 days after surgery.

Aperçu de l'étude

Statut

Pas encore de recrutement

Description détaillée

This prospective, single-center, randomized controlled study will be conducted by the Department of Anesthesiology and Reanimation at Kayseri City Hospital. Adults undergoing elective colon resection under general anesthesia will be randomized in a 1:1:1 ratio using a computer-generated randomization list. Allocation will be concealed in sequentially numbered, sealed opaque envelopes opened before the preoperative intervention. The planned sample size is 108 participants, with 36 participants per group.

Active prewarming will be applied in the preoperative preparation area using a forced-air warming system covering the upper and lower body. Device settings will follow manufacturer recommendations and institutional clinical standards. The two prewarming groups will receive 10 or 30 minutes of active warming before anesthesia. The control group will receive routine preoperative care without active prewarming. All groups will receive intraoperative warming and standard anesthesia monitoring and management.

Perfusion index and pleth variability index will be measured noninvasively using a pulse oximeter at postanesthesia care unit (PACU) admission and at 5 and 10 minutes. The primary analysis will compare the arithmetic mean of the three postoperative perfusion index measurements between groups. Arterial blood gas and lactate results will be obtained from routine clinical testing without an additional invasive procedure for research. Demographic characteristics, ASA physical status, anesthesia and surgical duration, perioperative temperature, and relevant intraoperative clinical variables will be recorded.

The primary outcome will be compared using one-way analysis of variance when distributional assumptions are met, or the Kruskal-Wallis test otherwise, with appropriate post-hoc comparisons. Repeated perfusion index measurements will also be examined for group and time effects. Secondary continuous and categorical outcomes will be analyzed with methods appropriate to their distributions. Associations of perfusion index with lactate, blood gas parameters, and pain scores will be examined using Pearson or Spearman correlation. Statistical significance will be set at p < 0.05.

The outcome assessor will be blinded to group assignment. Postoperative pain will be assessed using a 0-10 visual analogue scale at PACU admission and at 5 and 10 minutes. Wound infection will be assessed during the 14-day period following surgery.

Type d'étude

Interventionnel

Inscription (Estimé)

108

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Çiğdem Ünal Kantekin, MD
  • Numéro de téléphone: +90 505 443 3056
  • E-mail: drcgdm@hotmail.com

Lieux d'étude

      • Kayseri, Turquie (Türkiye), 38080
        • Kayseri City Hospital
        • Contact:
          • Çiğdem Ünal Kantekin, MD
          • Numéro de téléphone: +90 505 443 3056
          • E-mail: drcgdm@hotmail.com

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Age 18 years or older.
  • Scheduled for elective colon resection surgery under general anesthesia.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Willing to participate and able to provide written informed consent.

Exclusion Criteria:

  • Age younger than 18 years.
  • Emergency surgery.
  • Severe vascular disease that may affect peripheral circulation, such as advanced peripheral arterial disease.
  • Severe cardiovascular instability.
  • Fever (>38 degrees Celsius) or hypothermia (<36 degrees Celsius) before surgery.
  • Severe anemia (hemoglobin <8 g/dL).
  • Requirement for vasopressor or inotropic support.
  • A condition in the measurement limb that prevents perfusion index measurement, such as severe peripheral edema, an intravenous line, or involvement of the surgical field.
  • Refusal to participate.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: 10-Minute Prewarming

Participants receive 10 minutes of active forced-air warming in the preoperative preparation area before induction of general anesthesia. Warming covers the upper and lower body, with settings following manufacturer recommendations and institutional standards. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Active warming using a forced-air warming system in the preoperative preparation area before general anesthesia. The upper and lower body are warmed for 10 or 30 minutes according to randomized group assignment. Device temperature settings follow manufacturer recommendations and institutional clinical standards.

Expérimental: 30-Minute Prewarming

Participants receive 30 minutes of active forced-air warming in the preoperative preparation area before induction of general anesthesia. Warming covers the upper and lower body, with settings following manufacturer recommendations and institutional standards. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Active warming using a forced-air warming system in the preoperative preparation area before general anesthesia. The upper and lower body are warmed for 10 or 30 minutes according to randomized group assignment. Device temperature settings follow manufacturer recommendations and institutional clinical standards.

Aucune intervention: Control: No Prewarming

Participants receive routine preoperative care without active prewarming before induction of general anesthesia. All participants receive routine intraoperative warming as standard care. Standard anesthetic care is provided in all three groups.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Mean Postoperative Perfusion Index
Délai: At PACU admission and 5 and 10 minutes after admission

Perfusion index (PI) is measured noninvasively using a pulse oximeter at postanesthesia care unit (PACU) admission, 5 minutes, and 10 minutes. The primary outcome is the arithmetic mean of these three measurements. PI reflects the ratio of the pulsatile to nonpulsatile component of the photoplethysmographic signal and is used as an indicator of peripheral perfusion.

At PACU admission and 5 and 10 minutes after admission

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Postoperative Pleth Variability Index
Délai: At PACU admission and 5 and 10 minutes after admission

Pleth variability index (PVI) is measured noninvasively using a pulse oximeter at PACU admission, 5 minutes, and 10 minutes to compare early postoperative changes among the three study groups.

At PACU admission and 5 and 10 minutes after admission
Postoperative Arterial Lactate
Délai: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial lactate concentration, reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission. No additional arterial sampling is performed solely for this study.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial pH
Délai: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial pH obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Carbon Dioxide Partial Pressure
Délai: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial carbon dioxide partial pressure (PaCO2), reported in mmHg, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Oxygen Partial Pressure
Délai: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial oxygen partial pressure (PaO2), reported in mmHg, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Bicarbonate
Délai: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial bicarbonate concentration (HCO3), reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Arterial Base Excess
Délai: At postanesthesia care unit (PACU) admission (0 minutes)

Arterial base excess (BE), reported in mmol/L, obtained from routine arterial blood gas analysis at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Hemoglobin
Délai: At postanesthesia care unit (PACU) admission (0 minutes)

Hemoglobin concentration, reported in g/dL, recorded from routine blood gas testing at postanesthesia care unit (PACU) admission.

At postanesthesia care unit (PACU) admission (0 minutes)
Postoperative Shivering
Délai: From PACU admission through the first 30 minutes after admission

Number of participants with postoperative shivering. Shivering is recorded as present or absent during the first 30 minutes after postanesthesia care unit (PACU) admission.

From PACU admission through the first 30 minutes after admission
Time to Initiation of Oral Feeding
Délai: From the end of surgery until initiation of oral feeding, assessed up to 14 days after surgery

Time from the end of surgery to the first initiation of oral feeding, recorded in hours. Participants are followed for initiation of oral feeding for up to 14 days after surgery.

From the end of surgery until initiation of oral feeding, assessed up to 14 days after surgery
Postoperative Pain Score
Délai: At PACU admission and 5 and 10 minutes after admission

Pain intensity assessed using a visual analogue scale (VAS) from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Scores are recorded at PACU admission, 5 minutes, and 10 minutes. Higher scores indicate greater pain.

At PACU admission and 5 and 10 minutes after admission
Wound Infection Within 14 Days After Surgery
Délai: Within 14 days after surgery

Number of participants who develop a wound infection during the 14-day period following surgery. Wound infection is recorded as present or absent.

Within 14 days after surgery

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Çiğdem Ünal Kantekin, MD, Kayseri City Hospital

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

15 octobre 2026

Achèvement primaire (Estimé)

15 février 2027

Achèvement de l'étude (Estimé)

15 mars 2027

Dates d'inscription aux études

Première soumission

23 septembre 2026

Première soumission répondant aux critères de contrôle qualité

30 septembre 2026

Première publication (Réel)

5 octobre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

5 octobre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

30 septembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • KCH-PREWARM-2026-1080

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

De-identified individual participant data collected in this study will be made available to other researchers upon reasonable request to the principal investigator.

Délai de partage IPD

De-identified individual participant data will be available upon reasonable request beginning with publication of the primary results and continuing for 3 years after publication.

Critères d'accès au partage IPD

Researchers may request de-identified participant-level data by contacting the principal investigator, Çiğdem Ünal Kantekin, at drcgdm@hotmail.com. Requests will be considered on a reasonable-request basis.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner